Melissa Sen Phuong
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Melissa Sen Phuong has a total of 26 co-authors. Here are the top co-authors by number of shared publications:
Heather T. Whittaker
Faculty of Medicine and Health Sciences, McGill University, Montreal, QC, Canada
4 shared publicationsValera Castanov
Schulich School of Medicine and Dentistry, Western University, London, ON, Canada
4 shared publicationsWenxuan Wang
Schulich School of Medicine and Dentistry, Western University, London, ON, Canada
4 shared publicationsAdam Pietrobon
Faculty of Medicine, University of Ottawa, ON, Canada
2 shared publicationsAmelia T. Yuan
Schulich School of Medicine and Dentistry, Western University, London, ON, Canada
2 shared publicationsClaudia Turco
Faculty of Medicine, University of Alberta, Edmonton, AB, Canada
2 shared publications
Latest Publications
- 21 September 2022
- Published by University of Toronto Press Inc. (UTPress) in Clinical & Investigative Medicine
- Vol. 45 (3) , E1-E2
Fall 2022: Clinician Investigator Trainee Association of Canada (CITAC)
On behalf of the Clinical Investigator Trainee Association of Canada (CITAC) Board of Directors, I would like to extend an enthusiastic welcome to our new MD+ trainee members! I hope you soaked up all that summer had to offer and are in good back-to-school spirits. A new academic year is upon us, and opportunities abound for the Canadian physician scientist trainee community.
- 21 September 2022
- Published by University of Toronto Press Inc. (UTPress) in Clinical & Investigative Medicine
- Vol. 45 (3) , E1-E2
Fall 2022: Clinician Investigator Trainee Association of Canada (CITAC)
On behalf of the Clinical Investigator Trainee Association of Canada (CITAC) Board of Directors, I would like to extend an enthusiastic welcome to our new MD+ trainee members! I hope you soaked up all that summer had to offer and are in good back-to-school spirits. A new academic year is upon us, and opportunities abound for the Canadian physician scientist trainee community.
- 23 March 2022
- Published by University of Toronto Press Inc. (UTPress) in Clinical & Investigative Medicine
- Vol. 45 (1) , E1-E4
Spring 2022: Clinician Investigator Trainee Association Of Canada (CITAC)
Over the past two years, physician-scientist trainees have persevered in the face of evolving challenges presented by the ongoing coronavirus disease 2019 (COVID-19) pandemic. Research and healthcare institutions across the country continue to feel the impacts of the public health emergency. As scientists and physicians generate evidence to inform the prevention and treatment of COVID-19, physician-scientist trainees in all disciplines have adapted to the changing conditions of their education.
- 23 March 2022
- Published by University of Toronto Press Inc. (UTPress) in Clinical & Investigative Medicine
- Vol. 45 (1) , E1-E4
Spring 2022: Clinician Investigator Trainee Association Of Canada (CITAC)
Over the past two years, physician-scientist trainees have persevered in the face of evolving challenges presented by the ongoing coronavirus disease 2019 (COVID-19) pandemic. Research and healthcare institutions across the country continue to feel the impacts of the public health emergency. As scientists and physicians generate evidence to inform the prevention and treatment of COVID-19, physician-scientist trainees in all disciplines have adapted to the changing conditions of their education.
- Open Access
- 3 October 2021
- Published by University of Toronto Press Inc. (UTPress) in Clinical & Investigative Medicine
- Vol. 44 (3) , E4-E10
Overview of The Canadian Clinician Investigator Trainees’ Research Presented at The 2020 CSCI-CITAC Joint Meeting
The 2020 Annual General Meeting (AGM) and Young Investigators’ Forum of the Canadian Society for Clinical Investigation / Société Canadienne de Recherches Clinique (CSCI/SCRC) and Clinician Investigator Trainee Association of Canada/Association des Cliniciens-Chercheurs en Formation du Canada (CITAC/ACCFC) was the first meeting to be hosted virtually. The theme was “Navigating Uncertainty, Embracing Change and Empowering the Next Generation of Clinician-Scientists”, and the meeting featured lectures and workshops that were designed to provide knowledge and skills for professional development of clinician investigator trainees. The opening remarks were given by Jason Berman (President of CSCI/SCRC), Tina Marvasti (President of CITAC/ACCFC) and Nicola Jones (University of Toronto Clinician Investigator Program Symposium Chair). Dr. Michael Strong, President of the Canadian Institutes of Health Research, delivered the keynote presentation titled “CIHR’s COVID-19 Response and Strategic Planning”. Dr. John Bell (University of Ottawa) received the CSCI Distinguished Scientist Award, Dr. Stanley Nattel (Université de Montréal) received the CSCI-RCPSC Henry Friesen Award (RCPSC; Royal College of Physicians and Surgeons of Canada) and Dr. Meghan Azad (University of Manitoba) received the CSCI Joe Doupe Young Investigator Award. Each scientist delivered talks on their award-winning research. The interactive workshops were “Developing Strategies to Maintain Wellness”, “Understanding the Hidden Curriculum: Power and Privilege in Science and Medicine”, “Hiring a Clinician Scientist Trainee: What Leaders Are Looking For” and “COVID-19: A Case Study for Pivoting Your Research”. The AGM included presentations from clinician investigator trainees nationwide. Over 70 abstracts were showcased, most are summarized in this review, and six were selected for oral presentations.
- 3 October 2021
- Published by University of Toronto Press Inc. (UTPress) in Clinical & Investigative Medicine
- Vol. 44 (3) , E4-E10
Open AccessOverview of The Canadian Clinician Investigator Trainees’ Research Presented at The 2020 CSCI-CITAC Joint Meeting
The 2020 Annual General Meeting (AGM) and Young Investigators’ Forum of the Canadian Society for Clinical Investigation / Société Canadienne de Recherches Clinique (CSCI/SCRC) and Clinician Investigator Trainee Association of Canada/Association des Cliniciens-Chercheurs en Formation du Canada (CITAC/ACCFC) was the first meeting to be hosted virtually. The theme was “Navigating Uncertainty, Embracing Change and Empowering the Next Generation of Clinician-Scientists”, and the meeting featured lectures and workshops that were designed to provide knowledge and skills for professional development of clinician investigator trainees. The opening remarks were given by Jason Berman (President of CSCI/SCRC), Tina Marvasti (President of CITAC/ACCFC) and Nicola Jones (University of Toronto Clinician Investigator Program Symposium Chair). Dr. Michael Strong, President of the Canadian Institutes of Health Research, delivered the keynote presentation titled “CIHR’s COVID-19 Response and Strategic Planning”. Dr. John Bell (University of Ottawa) received the CSCI Distinguished Scientist Award, Dr. Stanley Nattel (Université de Montréal) received the CSCI-RCPSC Henry Friesen Award (RCPSC; Royal College of Physicians and Surgeons of Canada) and Dr. Meghan Azad (University of Manitoba) received the CSCI Joe Doupe Young Investigator Award. Each scientist delivered talks on their award-winning research. The interactive workshops were “Developing Strategies to Maintain Wellness”, “Understanding the Hidden Curriculum: Power and Privilege in Science and Medicine”, “Hiring a Clinician Scientist Trainee: What Leaders Are Looking For” and “COVID-19: A Case Study for Pivoting Your Research”. The AGM included presentations from clinician investigator trainees nationwide. Over 70 abstracts were showcased, most are summarized in this review, and six were selected for oral presentations.
- 3 October 2021
- Published by University of Toronto Press Inc. (UTPress) in Clinical & Investigative Medicine
- Vol. 44 (3) , E1-E3
Fall 2021: Clinician Investigator Trainee Association of Canada (CITAC)
I hope you’re taking care and found some time to relax this summer. A new semester may mean a big transition—some folks are starting their graduate studies, re-entering clerkship, starting residency or entering a fellowship. For some, there will be little or no change at all; but just a continuation of one of the many phases of the physician-scientist training pathway. Whatever stage you’re at, the Clinical Investigator Trainee Association of Canada (CITAC) community is here to support and advocate for you!
- 3 October 2021
- Published by University of Toronto Press Inc. (UTPress) in Clinical & Investigative Medicine
- Vol. 44 (3) , E1-E3
Fall 2021: Clinician Investigator Trainee Association of Canada (CITAC)
I hope you’re taking care and found some time to relax this summer. A new semester may mean a big transition—some folks are starting their graduate studies, re-entering clerkship, starting residency or entering a fellowship. For some, there will be little or no change at all; but just a continuation of one of the many phases of the physician-scientist training pathway. Whatever stage you’re at, the Clinical Investigator Trainee Association of Canada (CITAC) community is here to support and advocate for you!
- Open Access
- 17 April 2021
- Published by University of Ottawa Library in University of Ottawa Journal of Medicine
- Vol. 10 (2)
An Interview with the Ottawa Hospital’s Chief of Staff Dr. Virginia Roth
Dr. Virginia Roth is an infectious disease physician who has been the Ottawa Hospital’s Chief of Staff since 2018 and was the first woman to hold this position at TOH. An alumnus of the University of Ottawa Faculty of Medicine, she has also worked as an Epidemic Intelligence Service Officer at the U.S. Centers for Disease Control and Prevention (CDC) and as Director of Infection Control at TOH. She also holds an Executive MBA from the Telfer School of Management. We sat down with Dr. Roth in late-September to talk more about her career path and professional roles, the ongoing COVID-19 pandemic, and any advice for medical students as they navigate their own education and careers.
- 17 April 2021
- Published by University of Ottawa Library in University of Ottawa Journal of Medicine
- Vol. 10 (2)
Open AccessAn Interview with the Ottawa Hospital’s Chief of Staff Dr. Virginia Roth
Dr. Virginia Roth is an infectious disease physician who has been the Ottawa Hospital’s Chief of Staff since 2018 and was the first woman to hold this position at TOH. An alumnus of the University of Ottawa Faculty of Medicine, she has also worked as an Epidemic Intelligence Service Officer at the U.S. Centers for Disease Control and Prevention (CDC) and as Director of Infection Control at TOH. She also holds an Executive MBA from the Telfer School of Management. We sat down with Dr. Roth in late-September to talk more about her career path and professional roles, the ongoing COVID-19 pandemic, and any advice for medical students as they navigate their own education and careers.
- 21 March 2021
- Published by University of Toronto Press Inc. (UTPress) in Clinical & Investigative Medicine
- Vol. 44 (1) , E1-E4
Spring 2021: Clinician Investigator Trainee Association Of Canada (CITAC)
The Clinician Investigator Trainee Association of Canada (CI) trainees across the country around the common goal of improving training conditions for those pursuing a career at the junction of research and medicine. Since then, the CI training landscape has shifted dramatically. The number of Canadian CI trainees enrolled totaling 289 MD-PhD trainees and 389 Clinical Investigator Program (CIP) trainees as of 2019 [1]. Alumni outcome data have presented conclusive evidence that MD-PhD training programs are effective in producing CI careers [2–4].
- 21 March 2021
- Published by University of Toronto Press Inc. (UTPress) in Clinical & Investigative Medicine
- Vol. 44 (1) , E1-E4
Spring 2021: Clinician Investigator Trainee Association Of Canada (CITAC)
The Clinician Investigator Trainee Association of Canada (CI) trainees across the country around the common goal of improving training conditions for those pursuing a career at the junction of research and medicine. Since then, the CI training landscape has shifted dramatically. The number of Canadian CI trainees enrolled totaling 289 MD-PhD trainees and 389 Clinical Investigator Program (CIP) trainees as of 2019 [1]. Alumni outcome data have presented conclusive evidence that MD-PhD training programs are effective in producing CI careers [2–4].
- Open Access
- 13 September 2018
- Published by Open Library of the Humanities in The Comics Grid: Journal of Comics Scholarship
- Vol. 8 (1)
The Story of ECT: Behind the Scenes of a Controversial yet Effective Treatment
- 13 September 2018
- Published by Open Library of the Humanities in The Comics Grid: Journal of Comics Scholarship
- Vol. 8 (1)
Open AccessThe Story of ECT: Behind the Scenes of a Controversial yet Effective Treatment
- Open Access
- 10 November 2016
- Published by Springer Nature in Malaria Journal
- Vol. 15 (1) , 1-11
Parasitological correlates of Plasmodium ovale curtisi and Plasmodium ovale wallikeri infection
Malaria, due to Plasmodium ovale, can be challenging to diagnose due to clinically mild disease and low parasite burden. Two genetically distinct sub-species of P. ovale exist: Plasmodium ovale curtisi (classic) and Plasmodium ovale wallikeri (variant). It is presently unknown if the sub-species causing infection affects performance of malaria diagnostic tests. The aim of this work was to understand how the genetically distinct sub-species, P. o. curtisi and P. o. wallikeri, affect malaria diagnostic tests. Plasmodium ovale-positive whole blood specimens were sub-speciated by PCR and sequencing of 18S rRNA and dhfr-ts. Parasitaemia, morphology, pan-aldolase positivity, 18S copy number, and dhfr-ts sequences were compared between sub-species. From 2006 to 2015, 49 P. ovale isolates were identified, of which 22 were P. o. curtisi and 27 P. o. wallikeri; 80% were identified in the last five years, and 88% were acquired in West Africa. Sub-species did not differ by parasitaemia, 18S copy number, or pan-aldolase positivity. Lack of Schüffner’s stippling was over-represented among P. o. wallikeri isolates (p = 0.02). Several nucleotide polymorphisms between the sub-species were observed, but they do not occur at sites believed to relate to antifolate binding. Plasmodium ovale is increasing among travellers to West Africa, although sub-species do not differ significantly by parasitologic features such as parasitaemia. Absence of Schüffner’s stippling may be a feature specific to P. o. wallikeri and is a novel finding.
- 10 November 2016
- Published by Springer Nature in Malaria Journal
- Vol. 15 (1) , 1-11
Open AccessParasitological correlates of Plasmodium ovale curtisi and Plasmodium ovale wallikeri infection
Malaria, due to Plasmodium ovale, can be challenging to diagnose due to clinically mild disease and low parasite burden. Two genetically distinct sub-species of P. ovale exist: Plasmodium ovale curtisi (classic) and Plasmodium ovale wallikeri (variant). It is presently unknown if the sub-species causing infection affects performance of malaria diagnostic tests. The aim of this work was to understand how the genetically distinct sub-species, P. o. curtisi and P. o. wallikeri, affect malaria diagnostic tests. Plasmodium ovale-positive whole blood specimens were sub-speciated by PCR and sequencing of 18S rRNA and dhfr-ts. Parasitaemia, morphology, pan-aldolase positivity, 18S copy number, and dhfr-ts sequences were compared between sub-species. From 2006 to 2015, 49 P. ovale isolates were identified, of which 22 were P. o. curtisi and 27 P. o. wallikeri; 80% were identified in the last five years, and 88% were acquired in West Africa. Sub-species did not differ by parasitaemia, 18S copy number, or pan-aldolase positivity. Lack of Schüffner’s stippling was over-represented among P. o. wallikeri isolates (p = 0.02). Several nucleotide polymorphisms between the sub-species were observed, but they do not occur at sites believed to relate to antifolate binding. Plasmodium ovale is increasing among travellers to West Africa, although sub-species do not differ significantly by parasitologic features such as parasitaemia. Absence of Schüffner’s stippling may be a feature specific to P. o. wallikeri and is a novel finding.